Spurious Correlation in Estimation of the Health Production Function: A Note
KOF Working Papers No. 227
15 Pages Posted: 18 May 2009
Date Written: May 5, 2009
Abstract
In this paper, we address the issue of spurious correlation in the production of health in a systematic way. Spurious correlation entails the risk of linking health status to medical (and nonmedical) inputs when no links exist. This note first presents the bounds testing procedure as a method to detect and avoid spurious correlation. It then applies it to a recent contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health care expenditure. The results of the bounds testing procedure show longevity to be linearly related to these two factors. Therefore, the estimates reported by Lichtenber (2004) cannot be said to be result of spurious correlation, to the contrary, they very likely reflect an effective relationship, at least for the United States.
Keywords: health, life expectancy, innovation, pharmaceuticals, health care expenditure, cointegration
JEL Classification: H51, I12, J18, C22, C32, O33
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Recommended Papers
-
Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
-
The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
-
The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
-
Managed Care, Drug Benefits and Mortality: An Analysis of the Elderly
-
"Napsterizing" Pharmaceuticals: Access, Innovation, and Consumer Welfare
By James W. Hughes, Michael J. Moore, ...
-
The Cost of Us Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions
By Thomas A. Abbott and John A. Vernon
-
Intellectual Property and Marketing
By Darius N. Lakdawalla, Tomas Philipson, ...